A complete substitute amendment. v2 entirely replaces the operative text of v1, restructuring the definitions related to anti-doping policy and significantly revising the Office of National Drug Control Policy's authority and responsibilities concerning the World Anti-Doping Agency, including the determination process for WADA compliance and the conditions for withholding US dues.
Restoring Confidence in the World Anti-Doping Agency Act of 2025
- Sponsor
- Sen. Blackburn, Marsha [R-TN]
- Committees
- Commerce, Science, and Transportation Committee (primary)
- Last action
- Feb 23, 2026
Bottom line
The bill aims to increase U.S. oversight and influence over WADA's governance and athlete representation by empowering ONDCP with assessment, reporting, and financial leverage tools.
What it actually does
This bill amends the Office of National Drug Control Policy Reauthorization Act of 2006 to grant the Office of National Drug Control Policy (ONDCP) new authority over the World Anti-Doping Agency (WADA). It mandates annual assessments of WADA's governance, reform implementation, and athlete representation processes. If WADA fails to meet specified criteria, ONDCP is directed to use all available tools to achieve compliance, report to Congress on barriers, and may voluntarily withhold U.S. membership dues to WADA.
Proponents argue
Proponents argue that the bill is essential for ensuring WADA operates with credible, independent governance and fair representation for U.S. and other democratic athletes. They contend that stronger U.S. oversight is necessary to combat systemic doping fraud and restore confidence in global anti-doping efforts, particularly in light of past controversies regarding WADA's responsiveness and accountability.
Opponents contend
Critics might contend that this bill risks politicizing international anti-doping efforts and could undermine WADA's global authority and operational stability by introducing unilateral U.S. financial leverage. They may argue that withholding dues could weaken WADA's ability to effectively combat doping worldwide, potentially harming the very athletes the bill seeks to protect, and that international cooperation is more effective than nationalistic pressure.
The bill is relatively short and focused, making it accessible for an informed reader to evaluate within a reasonable timeframe.
Section 2(1)
Redefining Key Terms, Including 'Independent Athlete'
This provision amends the definitions section of the Office of National Drug Control Policy Reauthorization Act of 2006. Crucially, it redefines 'independent athlete' to mean a current or former amateur athlete who does not serve in any capacity on the International Olympic Committee, International Paralympic Committee, international sports federations, the United States Olympic and Paralympic Committee, national governing bodies, or WADA itself. This aims to ensure that athletes designated as 'independent' for decision-making roles truly lack conflicts of interest with major sports organizations.
Supporters argue
Proponents argue that this refined definition of 'independent athlete' is critical for ensuring that athlete voices in anti-doping governance are truly free from institutional influence or conflicts of interest, thereby strengthening the credibility of WADA's decision-making processes.
Critics contend
No specific opposition is typically raised against this provision, as clarifying definitions is generally seen as a technical improvement. However, some might argue that the definition could be overly restrictive, potentially limiting the pool of experienced athletes available for governance roles.
Tradeoffs
The provision balances the desire for truly independent athlete representation with the potential challenge of finding qualified individuals who meet the strict independence criteria.
Section 2(3), new subsection (d)(1)
Annual Assessment of WADA Governance and Athlete Representation
This provision mandates that the Office of National Drug Control Policy (ONDCP) conduct an annual determination, in consultation with the U.S. Anti-Doping Agency (USADA), the U.S. Olympic and Paralympic Committee (USOPC), and the Athletes' Advisory Council, to assess WADA. The assessment will determine if WADA has a credible and independent governance model with fair U.S. representation, fully implements governance reforms, and has fair processes for selecting independent athletes for decision-making roles on its Executive Committee, Foundation Board, and other groups.
Section 2(3), new subsection (d)(2) and (d)(3)
Accountability Measures and Reporting for WADA Non-Compliance
If ONDCP determines that WADA has not met the specified governance and representation criteria, this provision mandates two key actions. First, ONDCP must use "all available tools and best efforts" to bring WADA into compliance. Second, within 180 days of such a determination, ONDCP must submit a report to the appropriate committees of Congress detailing the barriers to U.S. participation and fair representation within WADA's governance structures.
Section 2(3), new subsection (d)(4)
Authority to Withhold WADA Membership Dues
This provision grants the Office of National Drug Control Policy (ONDCP) the discretion to voluntarily withhold up to the full amount of U.S. membership dues to WADA if WADA fails to meet the specified governance and representation criteria. Any funds withheld and not obligated by the end of the fiscal year would be returned to the general fund of the Treasury.
This subsection explicitly defines the 'appropriate committees of Congress' that ONDCP must consult with or report to. These include specific committees in both the Senate (Commerce, Science, and Transportation; Appropriations) and the House (Energy and Commerce; Appropriations).
Section 2(3), new subsection (d)(6)
Why it matters:This is standard legislative practice to define terms at the end of a section where they are used. It is not necessarily evasive, but its placement can make it less immediately apparent which specific congressional bodies are empowered by the bill.
Case for: Defining the specific committees ensures clarity and directs ONDCP's reporting and consultation obligations to the most relevant congressional bodies, streamlining oversight and accountability.
Case against: No specific case against, as this is a technical definition. However, if the committees were poorly chosen, it could lead to less effective oversight.
Estimated impact: Ensures that specific congressional committees responsible for commerce, science, transportation, energy, and appropriations are directly involved in the oversight of ONDCP's actions regarding WADA.
The bill changes the consulting body for ONDCP from the 'Team USA Athletes' Commission' (in the deleted text) to the 'Athletes' Advisory Council (established and maintained under section 220504(b)(2)(A) of title 36, United States Code)' in the reported version.
Section 2(3), new subsection (d)(1) and (d)(2)
Why it matters:This is a legislative amendment, where specific language is replaced. While not intentionally evasive, the nature of legislative drafting can make such changes less obvious than entirely new sections. It likely reflects a refinement in identifying the most appropriate athlete representative body.
Case for: Consulting with the Athletes' Advisory Council, a statutorily established body, ensures that ONDCP is engaging with a formally recognized and structured group representing U.S. athletes, potentially providing more consistent and authoritative input.
Case against: No direct case against, but some might argue that the 'Team USA Athletes' Commission' might have offered a different or broader perspective, depending on its structure and membership.
Estimated impact: Ensures ONDCP consults with a specific, statutorily defined athlete advisory body, potentially standardizing and formalizing athlete input into WADA oversight.